- Category
- Micro (2023-24)
- Udyam number
- UDYAM-DL-06-0056361

About Medwock Pharmaceuticals Private Limited
Data last updated:
Medwock Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 April 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24110DL2019PTC348789. Its GSTIN is 07AAMCM6104C1ZR (Delhi). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Reeta Devi (Whole-Time Director) and Amit Kumar Sharma (Whole-Time Director).
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at 310 Third Floor Lsc Market Block A Samrat Enclave, New Delhi, Delhi, India – 110034.
As per the financials filed for FY 2020, the company reported a revenue of ₹4.28 Lakh. For the same year it recorded a net profit of ₹237 (net margin 0.1%) and EBITDA of ₹2,267 (EBITDA margin 0.5%).
Medwock Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-06-0056361). For more details, the company can be reached via its website medwockpharma.com.
Company details
Recognitions & Rankings of Medwock Pharmaceuticals
Contact details
Medwock Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its website is medwockpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address310 Third Floor Lsc Market Block A Samrat Enclave, New Delhi, Delhi, India – 110034
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Medwock Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medwock Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Medwock Pharmaceuticals Private Limited, buy the company report.
Financials of Medwock Pharmaceuticals Private Limited
FY 2020 filings availableMedwock Pharmaceuticals Private Limited reported revenue of ₹4.28 Lakh for FY 2020.
Financial Statement Summary
| Metrics | FY 2019-20 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | ₹4.28 Lakh |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | ₹2,267 |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | ₹237 |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2019-20 |
|---|---|
| Profitability | |
| EBITDA Margin | 0.5% |
| Net Profit Margin | 0.1% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Medwock Pharmaceuticals Private Limited, buy the company report.
Board of directors of Medwock Pharmaceuticals Private Limited
Medwock Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Soni Jha | Additional Director | 11 Jul 2019 | 7 Years 3 Months | Current |
| Reeta Devi | Whole-Time Director | 18 Apr 2019 | 7 Years 6 Months | Current |
| Amit Kumar Sharma | Whole-Time Director | 18 Apr 2019 | 7 Years 6 Months | Current |
| Gunjan Shukla Also directs: Symvivo Pharmaceuticals Private Limited | Whole-Time Director | 18 Apr 2019 | 7 Years 6 Months | Current |
Peer comparison
Medwock Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Guyer Pharmaceuticals Private Limited | ₹4.29 Lakh (FY 2019) | -9.0% | Daltonganj, Jharkhand, India | |||
| True Pill Pharmaceuticals Private Limited | ₹4.28 Lakh (FY 2024) | 132.0% | Bulandshahar, Uttar Pradesh, India | |||
| Medwock Pharmaceuticals Private Limitedthis company | ₹4.28 Lakh (FY 2020) | ₹237 | 0.1% | New Delhi, Delhi, India | ||
| Sunchoice Pharmaceuticals Private Limited | ₹4.24 Lakh (FY 2024) | -5.0% | Moradabad, Uttar Pradesh, India |
To see the full peer comparison of Medwock Pharmaceuticals Private Limited, buy the company report.
Auditor
Medwock Pharmaceuticals Private Limited is audited by R D M & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R D M & CO | FY 2020 | 031000N |
Shareholding
The shareholding of Medwock Pharmaceuticals Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Medwock Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medwock Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medwock Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medwock Pharmaceuticals has 3 GST registrations: 2 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAMCM6104C1ZR | Delhi | Active | 21 May 2019 |
| 07AAMCM6104C3ZP | Delhi | Active | 21 Feb 2020 |
To see the full GST registrations and return filing status of Medwock Pharmaceuticals Private Limited, buy the company report.
Recent activity
Medwock Pharmaceuticals Private Limited has 5 board changes on record since 2019: 4 appointments and 1 cessation. The latest: Pawan ceased to be Additional Director on 13 Mar 2021.
Frequently asked questions
Medwock Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 April 2019 (7+ years old) and is registered under CIN U24110DL2019PTC348789.
Medwock Pharmaceuticals has 4 current directors:
- Reeta Devi - Whole-Time Director
- Amit Kumar Sharma - Whole-Time Director
- Gunjan Shukla - Whole-Time Director
- Soni Jha - Additional Director
The latest financial statements of Medwock Pharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Medwock Pharmaceuticals is 07AAMCM6104C1ZR, registered in Delhi. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 07AAMCM6104C3ZP (Delhi).
The CIN (Corporate Identification Number) of Medwock Pharmaceuticals is U24110DL2019PTC348789. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medwock Pharmaceuticals was incorporated on 18 April 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Medwock Pharmaceuticals by revenue are Guyer Pharmaceuticals Private Limited, True Pill Pharmaceuticals Private Limited, Sunchoice Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Pawan ceased to be Additional Director on 13 Mar 2021. Soni Jha was appointed as Additional Director on 11 Jul 2019. Amit Kumar Sharma was appointed as Whole-Time Director on 18 Apr 2019. Medwock Pharmaceuticals has 5 board changes on record in total.
Yes, Medwock Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-06-0056361).
Medwock Pharmaceuticals can be reached through the website medwockpharma.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Medwock Pharmaceuticals is at 310 Third Floor Lsc Market Block A Samrat Enclave, New Delhi, Delhi, India – 110034.

